KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Depreciation & Amortization (CF) (2017 - 2025)

Historic Depreciation & Amortization (CF) for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $2.4 million.

  • Bionano Genomics' Depreciation & Amortization (CF) fell 5779.0% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year decrease of 3700.39%. This contributed to the annual value of $14.0 million for FY2024, which is 229.06% up from last year.
  • According to the latest figures from Q3 2025, Bionano Genomics' Depreciation & Amortization (CF) is $2.4 million, which was down 5779.0% from $2.4 million recorded in Q2 2025.
  • Over the past 5 years, Bionano Genomics' Depreciation & Amortization (CF) peaked at $5.6 million during Q3 2024, and registered a low of $448000.0 during Q1 2021.
  • In the last 5 years, Bionano Genomics' Depreciation & Amortization (CF) had a median value of $2.4 million in 2024 and averaged $2.5 million.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 39330.36% in 2022, then plummeted by 5779.0% in 2025.
  • Bionano Genomics' Depreciation & Amortization (CF) (Quarter) stood at $1.9 million in 2021, then soared by 48.63% to $2.8 million in 2022, then soared by 30.01% to $3.6 million in 2023, then plummeted by 33.31% to $2.4 million in 2024, then decreased by 0.92% to $2.4 million in 2025.
  • Its Depreciation & Amortization (CF) was $2.4 million in Q3 2025, compared to $2.4 million in Q2 2025 and $2.4 million in Q1 2025.